Windlas Biotech Share Price
Windlas Biotech Share Price Today
As of 5 Jul 2026, Windlas Biotech share price is ₹867.00. The stock opened at ₹872.60, compared to its previous close of ₹861.25. During today's trading session, Windlas Biotech share price moved in the range of ₹860.15 to ₹891.10, with an average price of ₹875.63 for the day. Looking at its last 52-week, the stock has touched a low of ₹697.40 and a high of ₹1,097.90. On the performance front, Windlas Biotech share price has increased by 10.52% over the last six months and is down 3.26% on a year-on-year basis.
Windlas Biotech Returns Calculator
Windlas Biotech Shareholder Returns
Windlas Biotech Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,49,048.00 | 39.02 | 5.37 | 13.74% | 0.61 | 17.33% | 93.24 | 0.85% | 0.56 | 10.90 |
| Divis Laboratories | 1,77,179.00 | 69.00 | 10.57 | 15.32% | 0.00 | 19.56% | 629.49 | 0.45% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,57,804.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,17,642.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Dr. Reddy's Laboratories | 1,12,368.00 | 27.03 | 2.97 | 11.07% | 0.18 | 12.54% | 375.78 | 0.59% | 0.63 | 38.68 |
| Zydus Lifesciences | 1,10,651.00 | 21.60 | 4.08 | 18.59% | 0.31 | 17.35% | 235.25 | 0.09% | 0.39 | 35.38 |
| Lupin | 1,09,676.00 | 20.48 | 4.89 | 23.76% | 0.04 | 24.88% | 659.05 | 0.75% | 0.61 | 129.18 |
| Mankind Pharma | 1,02,729.00 | 53.00 | 6.30 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.54 | 49.37 |
| Aurobindo Pharma | 90,608.00 | 25.87 | 2.39 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 82,398.90 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
Windlas Biotech Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹759.88 | ₹630.96 | ₹513.08 | ₹465.93 |
| Other Income | ₹18.02 | ₹13.47 | ₹9.97 | ₹6.71 |
| Total Revenue | ₹777.90 | ₹644.42 | ₹523.05 | ₹472.64 |
| Total Expenses | ₹698.14 | ₹567.33 | ₹466.01 | ₹427.07 |
| Profit Before Tax | ₹79.76 | ₹77.09 | ₹57.04 | ₹45.57 |
| Tax | ₹18.76 | ₹18.90 | ₹14.41 | ₹7.48 |
| Profit After Tax | ₹60.99 | ₹58.19 | ₹42.63 | ₹38.09 |
| EPS - Basic | ₹29.19 | ₹27.97 | ₹19.70 | ₹18.58 |
| EPS - Diluted | ₹28.87 | ₹27.88 | ₹19.70 | ₹18.58 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹79.76 | ₹77.09 | ₹57.04 | ₹45.57 |
| Income before WC changes | ₹98.16 | ₹83.66 | ₹64.36 | ₹55.58 |
| Change in Assets | -₹57.64 | -₹5.52 | -₹25.36 | -₹62.63 |
| Change in Liabilities | ₹48.54 | ₹49.47 | ₹31.68 | ₹25.06 |
| Change in WC | -₹9.09 | ₹43.95 | ₹6.32 | -₹37.57 |
| Cash flow from Operations | ₹68.19 | ₹108.96 | ₹60.97 | ₹9.13 |
| Cash flow from Investing | -₹74.06 | -₹92.07 | -₹14.11 | -₹154.58 |
| Cash flow from Financing | ₹1.01 | -₹15.29 | -₹43.74 | ₹130.09 |
| Total Cash Flow | -₹4.86 | ₹1.60 | ₹3.12 | -₹15.36 |
| Cash (Start of the year) | ₹5.29 | ₹3.69 | ₹0.57 | ₹15.93 |
| Cash (End of the year) | ₹0.42 | ₹5.29 | ₹3.69 | ₹0.57 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹235.32 | ₹194.92 | ₹175.44 | ₹109.36 |
| Current Assets | ₹525.13 | ₹431.29 | ₹353.54 | ₹381.65 |
| Total Assets | ₹760.45 | ₹626.21 | ₹528.98 | ₹491.01 |
| Current Liabilities | ₹249.44 | ₹171.75 | ₹121.24 | ₹93.99 |
| Net Current Asset | ₹275.69 | ₹259.54 | ₹232.29 | ₹287.67 |
| Non-Current Liabilities | ₹5.24 | ₹4.52 | ₹5.46 | ₹2.25 |
| Equity Capital | ₹505.77 | ₹449.94 | ₹402.27 | ₹394.78 |
| Total Equity & Liabilities | ₹760.45 | ₹626.21 | ₹528.98 | ₹491.01 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹759.88 | ₹630.96 | ₹513.08 | ₹465.93 |
| Other Income | ₹17.65 | ₹13.47 | ₹9.97 | ₹6.71 |
| Total Revenue | ₹777.52 | ₹644.42 | ₹523.05 | ₹472.64 |
| Total Expenses | ₹698.13 | ₹567.40 | ₹465.99 | ₹426.60 |
| Profit Before Tax | ₹79.39 | ₹77.02 | ₹57.06 | ₹46.04 |
| Tax | ₹18.75 | ₹18.88 | ₹14.41 | ₹7.48 |
| Profit After Tax | ₹60.65 | ₹58.14 | ₹42.64 | ₹38.56 |
| EPS - Basic | ₹29.03 | ₹27.95 | ₹19.71 | ₹18.81 |
| EPS - Diluted | ₹28.71 | ₹27.86 | ₹19.71 | ₹18.81 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹79.39 | ₹77.02 | ₹57.06 | ₹46.04 |
| Income before WC changes | ₹97.81 | ₹83.62 | ₹64.40 | ₹55.79 |
| Change in Assets | -₹57.64 | -₹5.52 | -₹25.36 | -₹62.64 |
| Change in Liabilities | ₹48.93 | ₹49.43 | ₹31.66 | ₹24.73 |
| Change in WC | -₹8.71 | ₹43.91 | ₹6.29 | -₹37.91 |
| Cash flow from Operations | ₹68.23 | ₹108.91 | ₹60.98 | ₹9.00 |
| Cash flow from Investing | -₹74.06 | -₹92.07 | -₹14.11 | -₹154.31 |
| Cash flow from Financing | ₹1.01 | -₹15.29 | -₹43.74 | ₹130.09 |
| Total Cash Flow | -₹4.82 | ₹1.56 | ₹3.13 | -₹15.22 |
| Cash (Start of the year) | ₹5.24 | ₹3.69 | ₹0.55 | ₹15.78 |
| Cash (End of the year) | ₹0.42 | ₹5.24 | ₹3.69 | ₹0.55 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹235.32 | ₹194.92 | ₹175.47 | ₹109.39 |
| Current Assets | ₹525.13 | ₹431.24 | ₹353.54 | ₹381.63 |
| Total Assets | ₹760.45 | ₹626.16 | ₹529.01 | ₹491.03 |
| Current Liabilities | ₹249.42 | ₹171.35 | ₹120.88 | ₹93.65 |
| Net Current Asset | ₹275.70 | ₹259.89 | ₹232.65 | ₹287.98 |
| Non-Current Liabilities | ₹5.24 | ₹4.52 | ₹5.46 | ₹2.25 |
| Equity Capital | ₹505.79 | ₹450.29 | ₹402.67 | ₹395.13 |
| Total Equity & Liabilities | ₹760.45 | ₹626.16 | ₹529.01 | ₹491.03 |
About Windlas Biotech
Windlas Biotech Limited is a domestic pharmaceutical formulations contract development and manufacturing organization (CDMO). Its portfolio of CDMO solutions includes product development, licensing, and commercial manufacturing of complex drugs and dosage forms. Its product development and manufacturing capabilities in complex generic products by developing products, including alternate dosages, such as, medicated mouth sprays; coating technologies, including, pellet coating using bottom spray, API coating, pH dependent coating and nanosized crystals; nutraceuticals dosages, including, biscuits, protein powder, supplements, chocolate bars and malt based foods, and ayurvedic products, such as wellness products, hair oils and cough syrups. Its four fungible, Schedule-M compliant OSD/OLD manufacturing facilities are located in Dehradun, Uttarakhand, India. It specializes in manufacturing formulations, solid pharmaceutical dosage forms, liquid pharmaceutical dosage forms and injectables.
Windlas Biotech Financial Highlights
- Revenue: Windlas Biotech reported revenue of ₹921.89 crore in FY26 vs ₹777.90 crore in FY25. It showed an increase of 18.51% on a yearly basis.
- Operating Profit: Windlas Biotech reported an operating profit of ₹86.98 crore in FY26 vs ₹79.76 crore in FY25. It showed an increase of 9.05% on a year-on-year basis.
- Net Profit: Windlas Biotech reported a net profit of ₹66.46 crore in FY26 vs ₹60.99 crore in FY25. It showed an increase of 8.97% on a yearly basis.
Windlas Biotech Quarterly Result Highlights
- Windlas Biotech reported revenue of ₹242.85 crore in Mar 2026, compared with ₹237.67 crore in Dec 2025, representing an increase of 2.18% on a quarter-on-quarter (QoQ) basis.
- Windlas Biotech reported an operating profit of ₹20.16 crore in Mar 2026, compared with ₹19.97 crore in Dec 2025, representing an increase of 0.95% on a quarter-on-quarter (QoQ) basis.
- Windlas Biotech reported a profit of ₹15.99 crore in Mar 2026, compared with ₹15.00 crore in Dec 2025, reflecting an increase of 6.60% on a QoQ basis.
- The earnings per share (EPS) of Windlas Biotech stood at ₹29.19 during Mar 2026.
Similar Stocks
FAQs on Windlas Biotech Share Price
What is Windlas Biotech share price today?
Windlas Biotech share price is ₹867.00 as on 03 Jul, 2026, 15:29 IST.
How has the Windlas Biotech share price performed in the past?
In the last 1 year, Windlas Biotech delivered a return of -3.26%. The Windlas Biotech share price hit a high of ₹1,097.90 and low of ₹697.40.
How much is the Mutual Fund shareholding in Windlas Biotech shares?
The Mutual Fund Shareholding in Windlas Biotech was 6.41% at the end of May 2026.
What is the the 52-week high and low of Windlas Biotech shares ?
The 52-week high and low of Windlas Biotech share is ₹1,097.90 and ₹697.40 as of 03 Jul, 2026.
What is the market cap of Windlas Biotech?
The market capitalisation of Windlas Biotech is ₹1,777.60 Crores as on 03 Jul, 2026.
What are the stock symbols of Windlas Biotech?
The stock symbol of Windlas Biotech is WINDLAS on the NSE, 543329 on the BSE, and the ISIN is INE0H5O01029.
What was yesterday's closing price of Windlas Biotech shares ?
Windlas Biotech shares closed yesterday at ₹861.25 on NSE & ₹861.40 on BSE
How to buy Windlas Biotech shares?
To buy Windlas Biotech shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy Windlas Biotech shares on Holidays?
No, shares of Windlas Biotech or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Windlas Biotech shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of Windlas Biotech?
The PE and PB ratio of Windlas Biotech is 26.75 and 3.06 respectively, as on 03 Jul, 2026, 15:29 IST.